Truvic’s Prodigy Thrombectomy System Receives FDA 510(k) Clearance
April 11, 2022—Truvic Medical, Inc., a wholly owned subsidiary of Imperative Care, Inc., announced that it has received FDA 510(k) clearance for the Prodigy thrombectomy system, which is designed for the treatment of peripheral vascular thrombus.